Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Franklin, K. Carey, F. Vajdos, D. Leahy, A. Vos, M. Sliwkowski (2004)
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.Cancer cell, 5 4
Y. Li, Yong Pan, Yongkun Wei, Xiaoyun Cheng, Binhua Zhou, M. Tan, Xiaoyan Zhou, W. Xia, G. Hortobagyi, Dihua Yu, M. Hung (2004)
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.Cancer cell, 6 5
M. Marmor, Kochupurakkal Skaria, Y. Yarden (2004)
Signal transduction and oncogenesis by ErbB/HER receptors.International journal of radiation oncology, biology, physics, 58 3
(2014)
Purification of recombinant Pfu DNA polymerase by double step affinity chromatography
M. Pichon, K. Hacéne, S. Guepratte, R. Neumann (2004)
Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients.Clinical laboratory, 50 3-4
V. Oi (1980)
Immunoglobulin producing hybrid cell lines
Hyun-soo Cho, K. Mason, K. Ramyar, A. Stanley, S. Gabelli, D. Denney, D. Leahy (2003)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 421
Suhail Ali, K. Leitzel, V. Chinchilli, L. Engle, L. Demers, H. Harvey, W. Carney, J. Allard, A. Lipton (2002)
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.Clinical chemistry, 48 8
C. Gutierrez, R. Schiff (2011)
HER2: biology, detection, and clinical implications.Archives of pathology & laboratory medicine, 135 1
H. Son, Y. Shin, Kwang-Kuk Park, K. Seo, K. Yoon, H. Jang, Sang-Ho Lee, Song Yang, Jeong Kim (2014)
Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative ResectionJournal of Gastric Cancer, 14
A. Berghoff, R. Bartsch, M. Preusser, G. Ricken, G. Steger, Z. Bago-Horvath, M. Rudas, B. Streubel, P. Dubsky, M. Gnant, F. Fitzal, C. Zielinski, P. Birner (2014)
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.Breast, 23 5
G. Atalay, F. Cardoso, A. Awada, M. Piccart (2003)
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 14 9
(1980)
Antibody production by hybridoma
N. Cresti, Joanne Lee, Emma Rourke, D. Televantou, D. Jamieson, M. Verrill, A. Boddy (2016)
Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer.European journal of cancer, 55
M. Bradford (1976)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Analytical biochemistry, 72
The Oncologist® Academia–Pharma Intersect: Breast Cancer Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review
Di Wang, Huijun Zhu, Q. Ye, Chenyi Wang, Yunzhao Xu (2016)
Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian CancerMedicine, 95
M. Bajaj, M. Waterfield, J. Schlessinger, W. Taylor, T. Blundell (1987)
On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors.Biochimica et biophysica acta, 916 2
Coding (1980)
285J. Immunol. Meth, 39
S. Elias, Arthur Adams, D. Wisner, L. Esserman, L. Veer, W. Mali, K. Gilhuijs, N. Hylton (2014)
Imaging Features of HER2 Overexpression in Breast Cancer: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 23
J. Goding (1980)
Antibody production by hybridomas.Journal of immunological methods, 39 4
U. Laemmli (1970)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 227
W. Carney, D. Bernhardt, B. Jasani (2013)
Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?Biomarkers in Cancer, 5
S. Abeldenov, B. Khassenov (2014)
Cloning, expression and purification of recombinant analog of Taq DNA polymeraseBiotechnology. Theory and practice
L. Coussens, Teresa Yang−Feng, Y. Liao, E. Chen, A. Gray, J. Mcgrath, P. Seeburg, T. Libermann, J. Schlessinger, U. Francke, A. Levinson, A. Ullrich (1985)
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.Science, 230 4730
Human epidermal growth factor receptor 2 (HER2) is an important biomarker for detection and treatment of different types of cancers such as breast, ovarian, stomach cancer. In this study, we developed a monoclonal antibody against the extracellular domain (ECD) of HER2 biomarker of breast cancer. For this purpose, the ECD-HER2 gene was amplified and cloned into an expression vector. Gene was generated in Escherichia coli BL21 (DE3) strain for expression of recombinant protein. The expressed protein was separated by SDS-PAGE and detected by anti-his monoclonal antibody in immunoblotting. Hybridoma cells were obtained by fusing myeloma cells with mouse spleen cells injected with recombinant ECD-HER2 and screened by ELISA for the production of monoclonal antibody. The results indicate that out of three candidate hybridoma cells one clone (1E7) was producing the highest titer and antibody specificity was envisioned in ELISA results. In vivo scaling up culture of hybridoma cells in BALB/C mice lead to significant increase in the monoclonal antibody concentration up to 16 mg/ml. Immunochemical methods demonstrated the specificity of developed antibody against ECD-HER2 protein.
Human Antibodies – IOS Press
Published: Jan 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.